Insulet PODD
NASDAQ PODD
$134.58 -3.34 (-2.42%)
As of: Sep 10, 2026 · 2:54 PM EDT

Insulet (PODD) Accumulated Expenses (2010 - 2026)

Insulet's (PODD) quarterly Accumulated Expenses came in at $602.0 million in Q2 2026, up 32.77% on a YoY basis from $453.4 million in Q2 2025, and up 15.99% quarter-over-quarter from $519.0 million in Q1 2026.

Analysis

Insulet (PODD) Accumulated Expenses (2010 - 2026) Analysis & Trends

Insulet (PODD) has reported Accumulated Expenses for 17 consecutive years, with $602.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Accumulated Expenses rose 32.77% year-over-year to $602.0 million; the trailing twelve-month figure through Jun 2026 stood at $602.0 million (up 32.77% YoY), and the FY2025 full-year result was $586.7 million, up 38.41% from the prior year.
  • Accumulated Expenses climbed to $602.0 million in Q2 2026 per PODD's latest filing, from $519.0 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $602.0 million in Q2 2026 and bottomed at $135.8 million in Q1 2022.
  • Historically, Accumulated Expenses has averaged $371.1 million across 5 years, with a median of $369.3 million in 2023.
  • The sharpest annual moves came in 2023 and 2024: Accumulated Expenses jumped 94.11% in 2023, then advanced 13.43% in 2024.
  • Over 5 years, Accumulated Expenses stood at $301.0 million in 2022, then climbed by 24.15% to $373.7 million in 2023, then climbed by 13.43% to $423.9 million in 2024, then soared by 38.41% to $586.7 million in 2025, then advanced by 2.61% to $602.0 million in 2026.
  • According to Business Quant data, Accumulated Expenses over the past three periods registered $602.0 million, $519.0 million, and $586.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 180.76 Bn 175.16 Bn 7.27 Bn
2 Intuitive Surgical 127.77 Bn 122.55 Bn 1.96 Bn
3 Medtronic 117.20 Bn 108.39 Bn 6.34 Bn
4 Stryker 104.01 Bn 100.53 Bn 4.50 Bn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn
6 Edwards Lifesciences 49.80 Bn 45.55 Bn 1.35 Bn
7 Alcon 33.03 Bn 31.58 Bn 1.68 Bn
8 Dexcom 32.18 Bn 30.23 Bn 830.00 Mn
9 Steris 20.71 Bn 20.23 Bn 684.20 Mn
10 Insulet 9.35 Bn 8.82 Bn 562.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 602.00 Mn
Mar 31, 2026 519.00 Mn
Dec 31, 2025 586.70 Mn
Sep 30, 2025 518.70 Mn
Jun 30, 2025 453.40 Mn
Mar 31, 2025 378.60 Mn
Dec 31, 2024 423.90 Mn
Sep 30, 2024 414.20 Mn
Jun 30, 2024 365.00 Mn
Mar 31, 2024 308.60 Mn
Dec 31, 2023 373.70 Mn
Sep 30, 2023 319.20 Mn
Jun 30, 2023 282.80 Mn
Mar 31, 2023 263.60 Mn
Dec 31, 2022 301.00 Mn
Sep 30, 2022 241.70 Mn
Jun 30, 2022 192.50 Mn
Mar 31, 2022 135.80 Mn
Dec 31, 2021 164.30 Mn
Sep 30, 2021 141.70 Mn